Researchers from SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), will share results of their work in 30 presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, which takes place May 31 – June 4 in Chicago.
The clinical trials reported on in this work are led by SWOG and conducted by the NIH-funded NCI National Clinical Trials Network (NCTN) and the NCI Community Oncology Research Program (NCORP).
“I’m particularly proud of SWOG’s work at ASCO this year,” said Charles D. Blanke, MD, SWOG group chair, “not only because we’re presenting a record number of SWOG-led abstracts, including seven oral presentations, but also because many of those abstracts report the kind of life-changing results that come only from public-powered research – such as more accurate ways of determining which patients can safely skip additional chemotherapy, and how we can reduce some of the devastating side effects patients can experience during and after cancer treatment.”
Here are highlights of some of the SWOG work that will be delivered in oral presentations at the 2024 ASCO Annual Meeting:
Visit the SWOG website for a full list of SWOG research results being presented .
Work reported in abstract 505, led by Dr. Kalinsky, was funded by NIH/NCI grants U10CA180888, U10CA180819, and U24CA196175, and in part by Exact Sciences Corporation (previously Genomic Health, Inc.).
Work reported in abstract 508, led by Dr. Pusztai, was funded by NIH/NCI grants U10CA180888, U10CA180819, and U24CA196175, and in part by Exact Sciences Corporation (previously Genomic Health, Inc.) and The Hope Foundation for Cancer Research.
Work reported in abstract 4501, led by Dr. Hamilton-Reeves, was funded by NIH/NCI grants UG1CA189974, R37CA218118, and P30CA16852.
Work reported in abstract 11015, led by Dr. Unger, was funded by NIH/NCI/DCP grant UG1CA189974.
Work reported in abstract 12005, led by Dr. Trivedi, was funded by NIH/NCI grants UG1CA189974 and R37CA277043 and in part by The Hope Foundation for Cancer Research.
SWOG Cancer Research Network is part of the National Cancer Institute's National Clinical Trials Network and the NCI Community Oncology Research Program and is part of the oldest and largest publicly funded cancer research network in the nation. SWOG has 20,000 members in 45 states and nine other countries who design and conduct clinical trials to improve the lives of people with cancer. SWOG trials have directly led to the approval of 14 cancer drugs, changed more than 100 standards of cancer care, and saved more than 3 million years of human life. Learn more at swog.org, and follow us on Twitter (X) at @SWOG.
References:
Randomized controlled/clinical trial
People